47 reports

It is also being evaluated for the treatment of Crohn' s disease, psoriatic arthritis, and asthma.

  • Arthritis
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Arthritis
  • Neurological Disorder
  • United States
  • Demand
  • Market Size

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014

In this study, patients were randomized ##:##:##:##:## to receive once-daily doses of placebo or ##mg, ##mg, ##mg, or ##mg baricitinib for ##weeks.

  • Arthritis
  • Japan
  • United States
  • Pfizer Inc.
  • Roche Group
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Arthritis
  • Forecast
  • Market Size
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Arthritis
  • South America
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • World
  • Galapagos NV
  • Alphavirus Infections
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H1 2018

Also presented today are the results of a Phase ## study conducted in healthy subjects.

  • Arthritis
  • Chronic Pain
  • Australia
  • United States
  • World
  • Alphavirus Infections
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Cardiovascular Drug
  • Hepatitis
  • Therapy
  • Can-Fite BioPharma Ltd.

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Arthritis
  • Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • REJOIN - DRUG PROFILE
  • OSTEOARTHRITIS - DORMANT PROJECTS, H1 2018 (CONTD..4), H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Amgen Inc.

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Arthritis
  • Pain Relief
  • Research And Development
  • Therapy
  • Flex Pharma, Inc.
  • Number of Products under Development by Indication, H2 2017
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • Australia
  • Product Initiative

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Arthritis
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • DORMANT PRODUCTS, H2 2017 (CONTD..4), H2 2017
  • PIPELINE BY PFIZER INC, H2 2017

The small molecules were also under development for asthma and rheumatoid arthritis.

  • Arthritis
  • Chronic Disease
  • Therapy
  • United States
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..1), H2 2017

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Arthritis
  • Chronic Pain
  • World
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • R&D Progress

The primary outcome measure of the study is to assess the improvement in the severity of asthma as measured by change in the asthma control questionnaire (ACQ) score.

  • Arthritis
  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • INNOVIMMUNE BIOTHERAPEUTICS INC
  • INV-88 - DRUG PROFILE

Secondary endpoints include asthma exacerbation rate and the degree of asthma symptom control.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products

Encore presentation from the WCOG at ACG2017 ##.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

ABBVIE IS ALSO EVALUATING THE POTENTIAL OF THIS BIOLOGIC IN CROHN' S DISEASE, PSORIATIC ARTHRITIS, AND ASTHMA.

  • Arthritis
  • Biotech
  • United States
  • Company
  • Company Operations
  • R&D Progress
  • DALAZATIDE - DRUG PROFILE

AbbVie is also evaluating the potential of this biologic in Crohn' s disease, psoriatic arthritis, and asthma.

  • Arthritis
  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2017

Regeneron is also developing various product candidates in clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Arthritis
  • Chronic Pain
  • United States
  • World
  • Pfizer Inc.

Interleukin-##A (IL-##A) is a CD##+ T cell-derived cytokine that promotes inflammatory responses and is elevated in rheumatoid arthritis (RA), asthma, multiple sclerosis, psoriasis, and transplant rejection.

  • Arthritis
  • Autoimmune Disease
  • United States
  • Product Initiative
  • Novartis AG
  • Clinical Trial profile. 274 Trial Title
  • Clinical Trial Profile Snapshots

Patients were randomized to one of three treatment groups (##:##:##) and received either a single IA injection of ZILRETTA (## mg), normal saline-placebo or triamcinolone acetonide in crystalline suspension (TAcs) (## mg).

  • Arthritis
  • Clinical Trial
  • Musculoskeletal Disorder
  • Opioid
  • Pain Therapeutics
  • SYNTHETIC PEPTIDES FOR ALLERGIC ASTHMA AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • SODIUM HYPOCHLORITE - DRUG PROFILE

Rheumatoid Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • Pathology
  • Therapy
  • United States
  • Pfizer Inc.
  • OSTEOARTHRITIS - PIPELINE BY ORTHOCYTE CORP
  • OSTEOARTHRITIS - PIPELINE BY ONO PHARMACEUTICAL CO LTD

The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, anti-infectives, NSAIDs, anti-TB and cephalosporins.

  • Arthritis
  • United States
  • Company
  • Product Initiative
  • Amgen Inc.
  • Rheumatoid Arthritis

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

It targets JAK ##.

  • Arthritis
  • Belgium
  • United States
  • Company
  • Galapagos NV

In Period ##, subjects were randomized in a ##:##:##:## ratio to one of four treatment groups (three dosing groups and one placebo group) for ## weeks.

  • Arthritis
  • Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation